- Home
- RSSS vs ANIX Comparison
RSSS vs ANIX Comparison
Compare RSSS & ANIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RSSS
- ANIX
- Stock Information
- Founded
- RSSS 2006
- ANIX 1982
- Country
- RSSS United States
- ANIX United States
- Employees
- RSSS N/A
- ANIX N/A
- Industry
- RSSS Business Services
- ANIX Biotechnology: Pharmaceutical Preparations
- Sector
- RSSS Consumer Discretionary
- ANIX Health Care
- Exchange
- RSSS Nasdaq
- ANIX Nasdaq
- Market Cap
- RSSS 110.0M
- ANIX 95.7M
- IPO Year
- RSSS N/A
- ANIX 1987
- Fundamental
- Price
- RSSS $3.34
- ANIX $4.27
- Analyst Decision
- RSSS Strong Buy
- ANIX Strong Buy
- Analyst Count
- RSSS 1
- ANIX 3
- Target Price
- RSSS $5.00
- ANIX $9.00
- AVG Volume (30 Days)
- RSSS 108.7K
- ANIX 282.6K
- Earning Date
- RSSS 11-13-2025
- ANIX 09-10-2025
- Dividend Yield
- RSSS N/A
- ANIX N/A
- EPS Growth
- RSSS N/A
- ANIX N/A
- EPS
- RSSS 0.04
- ANIX N/A
- Revenue
- RSSS $49,057,981.00
- ANIX N/A
- Revenue This Year
- RSSS $5.79
- ANIX N/A
- Revenue Next Year
- RSSS $8.46
- ANIX N/A
- P/E Ratio
- RSSS $78.50
- ANIX N/A
- Revenue Growth
- RSSS 9.94
- ANIX N/A
- 52 Week Low
- RSSS $2.32
- ANIX $2.07
- 52 Week High
- RSSS $4.24
- ANIX $4.98
- Technical
- Relative Strength Index (RSI)
- RSSS 46.06
- ANIX 59.04
- Support Level
- RSSS $3.11
- ANIX $4.21
- Resistance Level
- RSSS $3.65
- ANIX $4.67
- Average True Range (ATR)
- RSSS 0.17
- ANIX 0.36
- MACD
- RSSS -0.06
- ANIX 0.02
- Stochastic Oscillator
- RSSS 32.78
- ANIX 58.85
About RSSS Research Solutions Inc
Research Solutions Inc is a holding company. The company provides vertical software-as-a-service ("SaaS") and artificial intelligence ("AI") solutions, providing software and related services to help research-intensive organizations simplify the research process, save time, and money. The company operates in a single segment, which derives its revenue from subscription fees from its cloud-based SaaS Platforms and transactional service fees for the electronic delivery of single articles. The company generates the majority of its revenue from the Transactions. Geographically, the company generates the majority of its revenue from the United States, followed by Europe.
About ANIX Anixa Biosciences Inc.
Anixa Biosciences Inc a cancer-focused biotechnology company, develops vaccines and therapies that are focused on critical unmet needs in oncology. The company is developing both diagnostics and therapeutics to detect cancer early, which is curable, and to treat those afflicted once diagnosed. Its segment includes CAR-T Therapeutics; Cancer Vaccines; Anti-Viral Therapeutics and others.